This report contains market size and forecasts of Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs in Global, including the following market information:
Global Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lipopeptides Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs include Cumberland Pharmaceuticals, Pfizer, Allergan Plc, Melinta Therapeutics Inc, Merck, Theravance Biopharma, Basilea Pharmaceutica, AmpliPhi Biosciences Corporation and Teva Pharmaceutical Industries Ltd and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs Market Segment Percentages, by Type, 2021 (%)
Lipopeptides Drugs
Oxazolidinones Drugs
Cephalosporin Drugs
Tetracycline Drugs
Folate Antagonist Drugs
Others
Global Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Others
Global Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cumberland Pharmaceuticals
Pfizer
Allergan Plc
Melinta Therapeutics Inc
Merck
Theravance Biopharma
Basilea Pharmaceutica
AmpliPhi Biosciences Corporation
Teva Pharmaceutical Industries Ltd
Debiopharm Group